Vivoryon Therapeutics (VVY.AS) Stock Price
€1.44 0.1%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Vivoryon Therapeutics, AI stock picks, stock alerts and much more.
VVY.AS AI Stock Analysis
AI stock analysis for VVY.AS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Vivoryon Therapeutics (VVY.AS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Vivoryon Therapeutics (VVY.AS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Vivoryon Therapeutics (VVY.AS), currently trading at €1.44, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About VVY.AS
-
Vivoryon Therapeutics N.
-
Symbol
VVY.AS
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
37.6M
Similar Stocks
 |
Valneva SE VLA.PA |
€5.05 2.4% |
5 |
 |
Financière de Tubize SA TUB.BR |
€160.6 0.4% |
8 |
 |
OSE Immunotherapeutics SA OSE.PA |
€6.32 0.5% |
6 |
 |
UCB SA UCB.BR |
€197.3 0.9% |
6 |
 |
Innate Pharma S.A. IPH.PA |
€2.01 1.9% |
5 |
VVY.AS Alternative Data
Web Traffic
Vivoryon Therapeutics receives an estimated 1601 monthly visitors to vivoryon.com.
-
Web Traffic
1601
-
Change from Previous Month
38.9%
-
3 Month Change
29.7%
-
YoY Change
29.7%
Job Postings
Vivoryon Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Vivoryon Therapeutics has 20 employees.
-
LinkedIn Employees
20
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Vivoryon Therapeutics is 100 out of 100 (very bullish).
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Vivoryon Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Vivoryon Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Vivoryon Therapeutics has 287 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
287
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
VVY.AS Financials
VVY.AS Key Metrics
-
Total Revenue
€0
-
Net Income
-€13.6M
-
Earnings per Share
-€0.52
-
Free cash flow
-€13.3M
-
EBITDA
-€13.8M
-
EBITDA Ratio
0
-
Total Assets
€11.3M
VVY.AS 2-year Revenue & Income
VVY.AS 2-year Free Cash Flow
VVY.AS Technicals
VVY.AS SMA
VVY.AS RSI
FAQ
What's the current price of Vivoryon Therapeutics (VVY.AS) Stock?
The price of an Vivoryon Therapeutics (VVY.AS) share is €1.44.
What's the market cap of Vivoryon Therapeutics?
The current market cap of Vivoryon Therapeutics is 37.6M.
Should I buy or sell VVY.AS?
Vivoryon Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Vivoryon Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Vivoryon Therapeutics a good investment?
The current analysis of Vivoryon Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Vivoryon Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Vivoryon Therapeutics (VVY.AS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Vivoryon Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Vivoryon Therapeutics (VVY.AS) that investors often compare it to?
Vivoryon Therapeutics (VVY.AS) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for Vivoryon Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Vivoryon Therapeutics' stock price to be around €1.43 in 2026. Starting from the current price of €1.44, this represents a 0.7% change in price, indicating a neutral outlook for the stock.
How to buy Vivoryon Therapeutics (VVY.AS) Stock?
Vivoryon Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Vivoryon Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.